Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Novel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) Achieved Greater Control of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Compared to Ravulizumab
-
Preclinical Study Shows Targeted Drug Strengthens the Power of CAR T-Cell Therapy in Two Pediatric Leukemias
-
Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
-
Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
-
Orca Bio Presents Clinical Results on Use of Orca-Q® without GvHD Prophylaxis in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
-
Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions
-
Syndax Presents Positive Revuforj® (revumenib) Data in Acute Leukemias from Multiple Trials, Including the SAVE Combination and AUGMENT-101 Trials, at 66th ASH Annual Meeting
-
Twenty-three Years Running for the Kids of St. Jude: St. Jude Memphis Marathon Weekend Reaches Fundraising Record
-
Caribbean Airlines Brings the Region Closer with New Service to Guadeloupe
-
New Data from PROMMIS Study Highlights the Power of SKY92 in Identifying High-Risk Multiple Myeloma Patients
-
MosquitoMate receives first Vector Expedited Review Voucher (VERV) from the US Environmental Protection Agency
-
Pennsylvania Skill, powered by Pace-O-Matic, Responds to Commonwealth Court Ruling in Favor of Skill Games
-
Building Homes for Heroes Gifts 400th Home, Marking Historic Achievement in Veteran and First Responder Support
-
HII Christens Virginia-Class Attack Submarine Arkansas (SSN 800)
-
United Flow Technologies Acquires The TDH Company to Enhance Water and Wastewater Treatment Solutions
-
Admirals Group AS Announces a Sale of its Australian Subsidiary
-
OpsHub Amplifies its Presence on the Visual Studio (VSTS) Marketplace
-
Updated Results of Phase 3 ALLELE Study Presented at 66th American Society of Hematology Annual Meeting Confirm Efficacy, Safety and Durability of Novel Allogeneic Cell Therapy Tabelecleucel in Relaps
-
Roswell Park Study Reveals How Venetoclax Boosts Immune Response to CAR T for Chronic Lymphocytic Leukemia
-
Blueprint Medicines' Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis Highlighted at 2024 ASH Annual Meeting
-
Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
-
Guan Hu's BLACK DOG Nominated for Best International Film For Film Independent Spirit Award
-
Edwards Lifesciences Corporation Investors: December 13, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
-
Fred Says Foundation Announces Its 2024 Gifts for World AIDS Day
-
Frank Biden: the Importance of COVID-19 Class Action Lawsuits in Pursuit of Justice and Accountability
-
Privee AI Announces New Magic AI Studio
-
Y-mAbs Presents SADA Platform Preclinical Data and Trial in Progress Posters at the 2024 American Society Hematology (ASH) Annual Meeting
-
Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients with Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH Meeti
-
Long-Term Follow-Up Data Continue to Support Beti-Cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Ind
-
MiNA Therapeutics Presents New Pre-Clinical Data from Lead Sickle Cell Disease Program at the American Society of Hematology Annual Meeting
-
Ethara: THE ART OF CURATING THE ABU DHABI GRAND PRIX HOSPITALITY EXPERIENCE
-
ACHC Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Acadia Healthcare Company, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit
-
Researchers Report New Opportunities to Improve Quality of Life for People with Non-Malignant Blood Disorders
-
Phase 2 data from the ongoing HIBISCUS study shows promise that investigational etavopivat could reduce the incidence of vaso-occlusive crises in people with sickle cell disease
-
Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting
-
Press Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP
-
CLASS ACTION NOTICE FOR ZETA: Kessler Topaz Meltzer & Check, LLP Reminds Zeta Global Holdings Corp. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Losses to Co
-
Blokees' Figures from Multiple IPs Amaze Fans at 2024 Singapore Comic Con
-
CLASS ACTION NOTICE FOR ZETA: Kessler Topaz Meltzer & Check, LLP Reminds Zeta Global Holdings Corp. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Losses to C
-
Envirotech Vehicles, Inc. (NASDAQ:EVTV) Announces 2024 Chairman’s Award
-
Ruul’s Crypto Payments: 9 Months In, 30% Adoption and Counting!
-
Important January 21, 2025 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Celsius Holdings, Inc. Investors of Securities Fraud Class Action Lawsuit
-
8 Creative Ways To Use Bulk Carnations In Your Arrangements
-
PACS Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds PACS Group, Inc. Investors of Securities Fraud Class Action Lawsuit Deadline
-
Research Shows How Lifestyle Factors and Diet Affect Hematologic Care
-
New Research from Children's Hospital of Philadelphia to Transform Standard of Care Across the Globe for Newly Diagnosed Children with B-cell Acute Lymphoblastic Leukemia
-
City of Hope Scientists Present Innovative Research on How High-Fiber Diets Can Improve Outcomes in Cancer Care
-
Kessler Topaz Meltzer & Check, LLP Announces Securities Fraud Class Action Lawsuit Filed Against Visa Inc.
-
BLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
-
Landmark Clinical Trial Results Offer New Hope for Kids with Acute Lymphoblastic Leukemia (ALL)
